ask="9.00"
ask_size="1100"
average_daily_volume="30444"
bid="3.12"
bid_size="100"
book_value="3.34"
change="-0.01"
change_from_200_day_moving_average="-0.30"
change_from_50_day_moving_average="1.59"
change_from_52_week_high="-3.51"
change_From_52_week_low="2.76"
change_in_percent="-0.16%"
close="6.28"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.58"
eps_estimate_next_quarter="-0.62"
eps_estimate_next_year="-2.83"
ex_dividend_date="N/A"
float_shares="1556000"
high="6.41"
high_52_weeks="9.79"
last_trade_date="1/4/2017"
last_trade_price="6.28"
last_trade_size="600"
last_trade_time="3:53pm"
low="6.19"
low_52_weeks="3.52"
market_capitalization="133.64M"
moving_average_200_day="6.58"
moving_average_50_day="4.69"
name="Nabriva Therapeutics AG - Ameri"
notes="N/A"
one_year_target_price="16.13"
open="6.36"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-4.57%"
percent_change_from_50_day_moving_average="+33.99%"
percent_change_from_52_week_high="-35.83%"
percent_change_from_52_week_low="+78.41%"
previous_close="6.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.88"
price_per_sales="25.74"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.75"
stock_exchange="NMS"
symbol="NBRV"
volume="22026"
weeks_range_52="3.52 - 9.79"
